Cantabio Pharmaceuticals Inc.

Tackling Neurodegenerative Diseases Head On

Cantabio Pharmaceuticals aims to slow, stop and even prevent the onset and progression of degenerative brain diseases such as Alzheimer’s and Parkinson’s disease.

Learn More

Drug Discovery Research

Cantabio strategically integrates therapeutic focus, target family biophysics, novel drug discovery technologies and expertise into innovative drug discovery approaches.

View Video

Cantabio in Biocentury Innovations

Cantabio Pharmaceuticals’ DJ-1 pharmacological chaperone program has been featured in Biocentury Innovations as the cover article for October 20th.

Read Article
Latest News Cantabio Pharmaceuticals to Present Results from Its Tau Protein Targeting Therapeutic Program for the Treatment of Alzheimer's Disease at the 13th International Conference on Alzheimer's and Parkinson's Disease Read More
OTCQB CTBO
Price Loading...
Change Loading...
Day Range Loading...
52 Wk Range Loading...

Toll-Free IR Helpline: (844) 200-CTBO